Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001301120-25-000033

Chief Scientific Officer sold 1,700 shares at $3.26 ($5,541)

  • Chief Scientific Officer acquired 1,700 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moreadith Randall · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-12 Exercise or conversion : show line 1 in the form 10b5-1 +1,700 $0.06 $102 1,700 D
2025-12-12 Sale : show line 2 in the form 10b5-1 −1,700 $3.26 $5,541 0 D
Open-market sales · 1,700 sh · avg $3.26 · $5,541

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-12 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −1,700 365,186 D
Loading xslF345X05/wk-form4_1765929561.xml…